Literature DB >> 12691540

Tetanus antitoxin levels among adults over 40 years of age in Central Anatolia, Turkey.

A Oztürk1, S Göahmetoğlu, F Erdem, S Mýsgüroğlu Alkan.   

Abstract

OBJECTIVE: To determine tetanus antitoxin levels in adults and the aged.
METHODS: This study was conducted on 249 adults over 40 years of age who applied to a blood-withdrawal unit in Kayseri, Central Anatolia. Tetanus toxoid-specific antibodies were measured in serum by enzyme-linked immunosorbent assay (ELISA).
RESULTS: In the research group, only 63 persons (25.3%) were found to have protective levels (>0.1 IU/mL) of tetanus antitoxin. Antibody levels were significantly higher in educated people (30.7%), in those under 50 years of age (38.2%), in those who had been vaccinated at least twice (47.6%), and in those vaccinated not more than 10 years previously (58.3%). There was no association between antibody level and sex, occupation or place of residence.
CONCLUSION: Our findings indicated that tetanus antibody values were under the protective level for most adults over 40 years of age, and vaccination programs directed at the adult population should be developed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691540     DOI: 10.1046/j.1469-0691.2003.00469.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups.

Authors:  K Caglar; R Karakus; C Aybay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

2.  Tetanus immunity in nursing home residents of Bolu, Turkey.

Authors:  Oguz Karabay; Fatma Ozkardes; Ali Tamer; Kazim Karaarslan
Journal:  BMC Public Health       Date:  2005-01-12       Impact factor: 3.295

3.  Tetanus immunity status among adult trauma patients in an ED.

Authors:  Ibrahim Toker; Turgay Yılmaz Kılıc; Sukran Kose; Murat Yesilaras; Feriyde Calıskan; Ozge Duman Atilla; Orkun Unek; Serkan Hacar; Aysin Kılınc Toker
Journal:  Turk J Emerg Med       Date:  2017-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.